Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.
The trial clearance for Shanghai-based Unixell is another step forward for the rapidly advancing Chinese biotech ecosystem, which has invested heavily in cell and gene therapy technology.
Researchers at OpenAI and Ginkgo Bioworks showed that an AI model working with an autonomous lab can design and iterate real ...
Miniature organs grown in the lab can organize themselves into complex shapes, which enables scientists to use them to study disease. The trouble is they never do it the same way twice, which has made ...
Atlassian offers a portfolio of software products designed to help organizations improve productivity. The company has infused artificial intelligence (AI) into its core products, which is driving ...
Paolo Aversa works on the Hot Snow project with professor Juliane Reinecke at the University of Oxford and professor Alberto Nucciarelli and Dr Edoardo Trincanato at the University of Trento. The ...
ABSTRACT: Fluid therapy has evolved dramatically from its origins in 17th-century blood transfusion experiments to sophisticated, modern, perioperative fluid management protocols. This comprehensive ...
Artificial Life (ALife) is primarily defined as the study and creation of systems that exhibit life-like properties, with the objective of understanding the fundamental principles of living systems, ...
You don’t want the bacterium Listeria monocytogenes inside your cells — it can make you seriously ill. Now, researchers at Aarhus University have used its unique mode of movement as inspiration to ...
Scott MacFarlane is CBS News' Justice correspondent. He has covered Washington for two decades, earning 20 Emmy and Edward R. Murrow awards. His reporting has resulted directly in the passage of five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results